Antibacterial wound dressings activated with tuned nanocomposites through the electrophoretic deposition techniques

ShimyaTech （ST）开发了一种创新技术，将纳米膜附着在固体支架上，用于医疗用途，以对抗细菌生物膜和伤口感染日益增长的影响。据报道，对伤口护理敷料产品的需求急剧增加，由于各种事件（从道路到剖腹产手术等）的增加，预计将进一步扩大，创新将提供新一代更安全，更具成本效益的产品，这将吸引投资，经济增长和对公共卫生及其成本的巨大利益。我们的技术建立在将调谐纳米材料复合材料附着在固体表面的应用之上，已被证明具有强大的功能，可用于医疗设备的涂层，包括伤口敷料。这将是预防感染传播的重要一步，这将导致NHS每年花费高达10亿英镑。我们已经克服了应用纳米颗粒的主要挑战，包括防止纳米颗粒逸出并释放到环境中，这可能对患者健康产生有害影响。在这个项目中，我们的目标是展示我们开发的技术在伤口敷料产品中的有效性和可扩展性，以及我们如何将其推向市场。需要快速采取一些关键步骤，为这项技术的商业化和推向市场做好准备。我们将通过组建一个强大的财团来推动该项目，以扩大该技术的规模，并在伤口敷料制造企业中启动工业应用。将研究市场需求和技术商业化的法规，并对伤口敷料原型进行调查。作为该项目的成果，将制作和传播公众意识和教育内容。

ShimyaTech (ST) has developed an innovative technology for the attachment of nanofilms on solid supports for medical usage to combat the growing impact of bacterial biofilms and wound infections. With the reported sharp increases in the demand for wound care dressing products, anticipated to further extend due to the increased figures of varied incidents (from road to caesarean procedures, etc.), the innovation will offer a new generation of safer and more cost-efficient products which will induce investment, economic growth and vast benefits to public health and its costs.Our technology, built on the application of tuned nanomaterial composites attached to solid surfaces, has proven strong features to use as coating on medical devices including wound dressings. This will be a major step in prevention of the spread of infection, which incurs major costs to NHS up to £1bn per year. We have overcome key challenges in applying nanoparticles including prevention of the escape of nanoparticles and their release to the environment, which can have a detrimental effect on patient health.In this project, we aim to demonstrate the efficacy and scalability of our developed technology application in wound dressing products, and also how we can take it to markets. Some critical steps are required to take at a fast pace to prepare the technology for commercialisation and introduction to markets. We will pursue the project by forming a strong consortium to lead the scaling up of the technology and launch industrial application at wound dressing manufacturing firms. Study of market requirements and regulations for commercialisation of the technology and the prototyped wound dressings will be investigated. Public awareness and educational contents will be produced and disseminated as outcomes from the project.